Curosurf Injection contains Poractant Alfa, a natural pulmonary surfactant used for the treatment of Respiratory Distress Syndrome (RDS) in premature newborn infants. It works by replacing the deficient lung surfactant, reducing surface tension in the lungs, improving oxygenation, and making breathing easier. It is administered directly into the baby's airway (intratracheally) by trained neonatal healthcare professionals.
✔️ Contains Poractant Alfa (Natural Lung Surfactant) 👶
✔️ Treats Neonatal Respiratory Distress Syndrome (RDS) 🫁
✔️ Improves Lung Function & Oxygenation 💙
✔️ Helps Reduce Respiratory Complications 🛡️
✔️ Hospital & NICU Use Only ✅
✔️ Replaces missing lung surfactant in premature infants 🫁
✔️ Improves breathing and oxygen exchange 👶
✔️ Helps reduce the severity of Respiratory Distress Syndrome 💙
✔️ Supports healthy lung expansion after birth 🌿
✔️ May reduce the risk of RDS-related complications and mortality when used appropriately.
✅ Premature newborn infants diagnosed with Respiratory Distress Syndrome (RDS)
✅ Infants requiring surfactant replacement therapy as determined by a neonatologist
🔹 Administered intratracheally (into the lungs through an endotracheal tube).
🔹 Given only by trained NICU/neonatal healthcare professionals.
🔹 Dosage is based on the infant's birth weight and clinical condition.
⚠️ For hospital use only.
⚠️ Must be administered by experienced neonatal healthcare professionals.
⚠️ Continuous monitoring of breathing, oxygen levels, and heart rate is required after administration.
⚠️ Temporary oxygen desaturation, bradycardia, or airway blockage may occur during administration.
📦 Fast Nationwide Delivery Across Pakistan 🚚
💯 100% Genuine & Authentic Product ✅
🏥 Trusted Pharmacy Service 💙
💸 Affordable Prices & Excellent Customer Support 🌟
